What is Kane Biotech Inc. (KNBIF)?

Kane Biotech Inc. (KNBIF) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of KNBIF?

The current price of KNBIF is $0.02. Prices are updated in real time on Stocks360.

What is KNBIF's price-to-earnings (PE) ratio?

KNBIF's trailing twelve-month PE ratio is -2.40, based on current price and earnings per share data available on Stocks360.

What is KNBIF's market capitalization?

KNBIF's market capitalization is $4,285,682.00, placing it in the small-cap tier.

Kane Biotech Inc. (KNBIF)

Stock analysis · OTC · Healthcare · Biotechnology

$0.02

Market Cap

$4.29M

PE (TTM)

-2.40

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.31

Day Range

$0.02 – $0.02

52-wk Range

$0.01 – $0.03

Avg Volume

N/A

Volume

3.40K

Kane Biotech Inc. (KNBIF) is a publicly traded company in the Healthcare sector. Latest price: $0.02. Market cap $4.29M. Trailing PE -2.40. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $0.03 2026-10-27 · $0.02 (-27.93%)

Earnings

Next Earnings

Nov 26, 2026

EPS estimate $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About Kane Biotech Inc.

Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company's diverse product lineup includes pet dental care solutions under the StrixNB and bluestem brands, as well as DispersinB for treating wounds in both animals and humans. They also manufacture Alosera shampoos for dogs, cats, and horses, and Aledex coatings for medical devices. Additionally, Kane Biotech provides DermaKB products for scalp health, Coactiv+ for wound management, and other offerings such as goldstem, silkstem, and DermaKB Biofilm. Founded in 2001, Kane Biotech Inc. is headquartered in Winnipeg, Canada.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-2.40×
P/S (TTM)	185.36×
P/B	-7.22×
PEG	0.08×
P/FCF (TTM)	-2.96×
EV / EBITDA	-2.70×
EV / Sales	213.99×
Earnings Yield	-37.66%
Free Cash Flow Yield	-33.75%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$8.29M
Revenue (TTM)	$38.72K
Net Income (TTM)	-$2.70M
Free Cash Flow (TTM)	-$2.42M
Net Debt	$1.11M
Working Capital	-$988.70K
Gross Margin	-503.12%
Operating Margin	-8113.83%
Net Margin	-6980.20%
Return on Equity	273.53%
Return on Invested Capital	-312.58%